Hepatologia
Prof.ª Doutora Helena Cortez-Pinto
Hot topics do EASL HCC Summit 2019
Prof.ª Doutora Cecília Rodrigues
Medicina Personalizada abre caminhos promissores para o tratamento do carcinoma hepatocelular
Prof. Doutor Shahid Khan
Epidemiologia, fatores de risco e gestão do colangiocarcinoma
Prof. Doutor Jesús Bañales
Desafios do colangiocarcinoma: novas ferramentas de diagnóstico
Prof. Doutor Peter Shirmacher
Nova classificação assume impacto no diagnóstico e terapêutica do colangiocarcinoma
Prof. Doutor Salvatore Petta
Rastreio do carcinoma hepatocelular em populações em risco
Prof.ª Doutora Jessica Zucman-Rossi
Vantagens da identificação de subtipos moleculares de carcinoma hepatocelular para a abordagem terapêutica
Flashes: EASL HCC Summit 2019 traz a Lisboa a discussão dos novos avanços em carcinoma hepatocelular
Ricardo Baptista Leite
Elimination of hepatitis C by 2030: Portugal goals
On the way to INHSU 2019
A tour through INHSU 2018 in two minutes
Rui Tato Marinho
INHSU 2018 has brought the opportunity to compare different models of care between different countries
Jason Grebely
INHSU 2018 “really offered an opportunity for driving forward policy change in the fight to end viral hepatitis in people who inject drugs”
Jeffrey Lazarus
Highlights from INHSU 2018: new models of care and broader issues in drug user health
Karine Lacombe
Point-of-care testing and diagnostics for HCV infection: the importance of screening
Stine Høj’
Applying the candidacy framework to inform research and practice in HCV care for people who use drugs
Shruti Mehta
Monitoring is an important step when thinking about strategies to facilitate linkage to care for people who use drugs
Behzad Hajarizadeh
Overwhelming evidence demonstrates hepatitis C treatment effective for people who inject drugs
Annette Verster
WHO establishes five key interventions to reduce the incidence of hepatitis C all around the world
Mojca Matičič
Models of care for HCV infection from all over the world improve the health of people who use drugs
INHSU 2018: the largest meeting with over more than seven hundred participants
Alain Litwin
“Shaping tomorrow together: insights from experience”
Alexis Goosdeel
EMCDDA points out the need to address late diagnosis for hepatitis C among people who use drugs
Erin O’Mara
Seeing the person with hepatitis C through a holistic perspective provides a more complete treatment
Rui Miguel Coimbra Morais
“Drug consumption rooms” may be a way to improve the health of people who use drugs
Prof.ª Doutora Adélia Simão
“Ainda são relativamente poucos aqueles que entre nós assumem a Hepatologia como sua atividade principal”
Photo gallery #2: INHSU 2018 wants to motivate policy champions in drug user health and hepatitis C elimination
Rui Tato Marinho
Clinical perspective: hepatitis C care in Portugal
Judy Chang
Best practises and policies to enhance drug user health: perspective from the community
João Goulão
Policy perspective: decriminalization and harm reduction in Portugal
Isabel Aldir
“If our goal is eliminate this kind of infections, we must work all together”
Ricardo Baptista Leite
Joint Action Policy Day marked by the launch of a Global Declaration to Eliminate Hepatitis C in People Who Use Drugs
Mariam Jashi
“We have to absorb more the experience of Portugal”
Photo gallery #1: Policy makers from all over the world meet to see how Portugal addresses hepatitis C in people who use drugs
Luis Mendão
IN-Mouraria: a Portuguese project that provides an integrated response center for people who use drugs
Huro Faria
Ares do Pinhal Association goes to the street to meet and treat dependent population
Saimone Macuaina
“I want to transfer this experience from Portugal to my country, Mozambique”
Portuguese National Parliament hosts Joint Action Policy Day
INHSU 2018: Explore the programme
Portugal holds the 7th International Symposium on Hepatitis Care in Substance Users
Prof. Doutor Jason Grebely
“A prevalência da hepatite C em pessoas que utilizam drogas injetáveis é superior a 50%”
Prof. Doutor Rui Tato Marinho
Falta de vacinas a nível mundial e hepatite B em destaque no VHPB Meeting
Dr.ª Adélia Simão
Adictologia
Alergologia
Andrologia
Anestesiologia
Biologia
Biologia Molecular
Cardiologia
Ciências Farmacêuticas
Cirurgia
Cirurgia Pediátrica
Cuidados Intensivos
Cuidados Paliativos
Dermatologia
Dor
Endocrinologia, Diabetes e Metabolismo
Enfermagem
Engenharia Biológia
Especial Doenças Raras
Especial Enxaqueca
Especial Tiroide
Especial Vitamina D
Farmácia
Farmácia Hospitalar
Gastrenterologia
Geriatria
Ginecologia
Ginecologia Oncológica
Hematologia
Hipertensão
Imagiologia
Imuno-hemoterapia
Imunologia
Imunologia Especial
Infecciologia
Infecciologia Especial
Infecciologia Pediátrica
Investigação
Medicina Clínica
Medicina da Reprodução
Medicina Dentária
Medicina Geral e Familiar
Medicina Intensiva
Medicina Interna
Medicina Paliativa
Microbiologia
Nefrologia
Neurologia
Neuropsicologia
Neurorradiologia
Nutrição
Obesidade
Oftalmologia
OncoConnect
Oncologia
Opinião
Ortopedia
Otoneurologia
Otorrinolaringologia
Patologia
Pediatria
Pneumologia
Podologia
Psicologia
Psiquiatria
Radiologia
Radioterapia
Reumatologia
Saúde
Saúde Pública
Urgência
Uro-Oncologia
Uroginecologia
Urologia
Virologia